-
Mashup Score: 0Oncology Drug Crash Course: Elacestrant (Orserdu) - 7 month(s) ago
Kristine Gibbons, RN, OCN, who is a Nurse Trainer at Florida Cancer Specialists & Research Institute, provides an in-depth look at elacestrant in a downloadable fact sheet.
Source: www.oncnursingnews.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Oncology Drug Crash Course: Elacestrant (Orserdu) - 7 month(s) ago
Kristine Gibbons, RN, OCN, who is a Nurse Trainer at Florida Cancer Specialists & Research Institute, provides an in-depth look at elacestrant in a downloadable fact sheet.
Source: www.oncnursingnews.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Kristine Gibbons, RN, OCN, who is a Nurse Trainer at Florida Cancer Specialists & Research Institute, provides an in-depth look at elacestrant in a downloadable fact sheet. #oncology #nursing #oncologynursing #bcm https://t.co/uW6fOFm2I5
-
-
Mashup Score: 0Oncology Drug Crash Course: Elacestrant (Orserdu) - 7 month(s) ago
Kristine Gibbons, RN, OCN, who is a Nurse Trainer at Florida Cancer Specialists & Research Institute, provides an in-depth look at elacestrant in a downloadable fact sheet.
Source: www.oncnursingnews.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Kristine Gibbons, RN, OCN, who is a Nurse Trainer at Florida Cancer Specialists & Research Institute, provides an in-depth look at elacestrant in a downloadable fact sheet. #oncology #nursing #oncologynursing #bcm https://t.co/uW6fOFm2I5
-
-
Mashup Score: 0Remaining Unmet Needs in the Third-Line and Lessons from HER2CLIMB - 9 month(s) ago
Drs Tripathy and Kaklamani emphasize the most critical unmet needs for patients with HER2+ metastatic breast cancer in the third-line or higher settings and recap what the field previously learned from the HER2CLIMB trial of tucatinib/trastuzumab/capecitabine.
Source: www.onclive.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
WATCH: @DrDebuTripathy & @VKaklamani emphasize the most critical unmet needs for patients with HER2+ metastatic #BreastCancer in the 3rd-line or higher settings and recap what the field learned from the HER2CLIMB trial. #bcm https://t.co/9Q1K2RGYiG https://t.co/Gxb9MQnQir
-
-
Mashup Score: 0Dr. Lustberg on the Real-World Use of Ovarian Suppression in HR+/HER2+ Breast Cancer - 1 year(s) ago
Maryam Lustberg, MD, MPH, discusses the real-world use of ovarian suppression therapy in clinical practice for premenopausal patients with hormone receptor-positive, HER2-positive breast cancer.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Watch: Maryam Lustberg, MD, of @YNHH, discusses the real-world use of ovarian suppression therapy in clinical practice for premenopausal patients with hormone receptor-positive, HER2-positive breast cancer. #bcm https://t.co/5RQtY44dUn
-
-
Mashup Score: 0BCM Registry : Home - 2 year(s) ago
Purpose The Purpose of the Registry is to collect data over time from patients with BCM from all over the world. The Registry aims to increase knowledge about: Clinical features of BCM; Natural course of BCM; Long-term outcomes of BCM; And…
Source: www.bcmregistry.orgCategories: Latest Headlines, Rare DiseaseTweet-
The @BCM_Families Registry is an online patient registry dedicated to #BlueConeMonochromacy (BCM) that collects and analyzes patients’ personal and clinical data. If you have received a genetic diagnosis of #BCM, join the #BCM Registry! More: https://t.co/YUpYEhs38J #Cure4BCM
-
-
Mashup Score: 1OncLive - Clinical Oncology News, Cancer Expert Insights - 2 year(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Thank you to @DrDebuTripathy, of @MDAndersonNews, for stopping & speaking w/ us about the 2022 #MiamiBreast conference & his presentation on primer in genomics and it’s application in the clinic in 2022. Hear more from Dr. Tripathy at https://t.co/E5LOd0oiTe! @gotoPER #bcm https://t.co/4VbjIw3LVN
-
-
Mashup Score: 0
Recruiting men age 50-64, this study aims to develop early detection methods for HPV-related cancers. HPV-related throat cancer is on the…
Source: Baylor College of MedicineCategories: Latest Headlines, OtolaryngologyTweet-
Dr. Sturgis is leading the TRINITY clinical trial & is working to establish early screening methods, which could help identify cancer before it requires treatment. We are recruiting men ages 50-64. Read HERE: https://t.co/mM0BiYqewB #HPV #CancerScreening #BCM #Otolaryngology https://t.co/62pYEXGjpy
-
-
Mashup Score: 2
Recruiting men age 50-64, this study aims to develop early detection methods for HPV-related cancers. HPV-related throat cancer is on the…
Source: Baylor College of MedicineCategories: Latest Headlines, OtolaryngologyTweet-
Dr. Sturgis is leading the TRINITY clinical trial & is working to establish early screening methods, which could help identify cancer before it requires treatment. We are recruiting men ages 50-64. Read HERE: https://t.co/mM0BiYqewB #HPV #CancerScreening #BCM #Otolaryngology https://t.co/1Jh9V1lSbV
-
-
Mashup Score: 0Coordinator, Business Operations - 3 year(s) ago
Coordinator, Business Operations
Source: jobs.bcm.eduCategories: Latest Headlines, OtolaryngologyTweet-
WE ARE HIRING! Our department are looking for an enthusiastic and experienced Business Operations Coordinator to join our growing OTO team! If you are interested in applying, please do so via the link HERE: https://t.co/kOBpreG2mp #recruiting #joinourteam #BCM https://t.co/KSrP52W5bP
-
Kristine Gibbons, RN, OCN, who is a Nurse Trainer at Florida Cancer Specialists & Research Institute, provides an in-depth look at elacestrant in a downloadable fact sheet. #oncology #nursing #oncologynursing #bcm https://t.co/uW6fOFm2I5